India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 16.55
Tata Stl 106.75 2.15
Vedl 304.75 9.66
State Ba 610.80 7.20
Ntpc Ltd 175.80 4.24
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Lupin Limited
Lupin Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:500257NSE:LUPINBloomberg:[email protected]Reuters:LUPN.BO
Market Lot: 1Face Value: 2ISIN Demat: INE326A01037
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
08-Mar-2022       Lupin signs Mary Kom as brand ambassador for Shakti initiative IRIS
09-Feb-2022       Lupin gets USFDA's nod for Arformoterol Tartrate Inhalation Solution IRIS
28-Jan-2022       Lupin signs promotional agreement with Exeltis  IRIS
18-Jan-2022       Lupin gets nod to acquire portfolio of brands of Anglo-French Drugs & Industries IRIS
14-Dec-2021       Lupin's Goa manufacturing plant gets EIR from USFDA IRIS
06-Dec-2021       Lupin enters into pact with Biomm IRIS
29-Sep-2021       Lupin launches Droxidopa Capsules in United States IRIS
07-Sep-2021       Lupin and TB Alliance announce commercial partnership for new therapy IRIS
25-Aug-2021       Lupin arm launches Luforbec for asthma and COPD treatment in UK IRIS
16-Aug-2021       Lupin receives tentative USFDA nod for Brivaracetam Tablets IRIS
17-Jun-2021       Lupin receives USFDA nod for Sevelamer Hydrochloride Tablets IRIS
07-Jun-2021       Lupin launches Digital Asthma Educator platform IRIS
07-Jun-2021       Lupin receives USFDA nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets IRIS
04-Jun-2021       Lupin launches authorized generic version of Brovana in United States IRIS
03-Jun-2021       Lupin to enter digital helthcare space in India IRIS
03-Jun-2021       Lupin announces USFDA acceptance for Pegfilgrastim Biosimilar application IRIS
27-May-2021       Lupin receives payment of USD 50 mn from Boehringer Ingelheim  IRIS
10-May-2021       Lupin enters into licensing agreement with Lilly  IRIS
23-Apr-2021       Lupin incorporates wholly owned subsidiary in USA  IRIS
24-Mar-2021       LupinLife partners with Uttarakhand Police to promote Hand Hygiene at Kumbh Mela 2021 IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer